Ascend Wellness Holdings (AAWH) Depreciation & Amortization (CF) (2020 - 2026)
Ascend Wellness Holdings (AAWH) recorded quarterly Depreciation & Amortization (CF) of $18.3 million in Q1 2026, down 10.96% quarter-over-quarter from $20.5 million in Q4 2025, and down 0.65% on a YoY basis from $18.4 million in Q1 2025.
Ascend Wellness Holdings (AAWH) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Depreciation & Amortization (CF) history runs 7 years deep, the most recent figure standing at $18.3 million for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) fell 0.65% year-over-year to $18.3 million; the TTM figure through Mar 2026 stood at $73.4 million (up 7.68% YoY), while the FY2025 annual figure was $73.5 million, up 11.14% from the prior year.
- Depreciation & Amortization (CF) was $18.3 million for Q1 2026 at Ascend Wellness Holdings, down from $20.5 million in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $21.9 million in Q1 2023 to a low of $7.3 million in Q2 2023.
- Historically, Depreciation & Amortization (CF) has averaged $14.9 million across 5 years, with a median of $16.4 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Depreciation & Amortization (CF) soared 121.22% in 2023, then fell 25.35% in 2024.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $11.3 million in 2022, then soared by 31.1% to $14.8 million in 2023, then rose by 18.1% to $17.5 million in 2024, then grew by 17.52% to $20.5 million in 2025, then decreased by 10.96% to $18.3 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $18.3 million (Q1 2026), $20.5 million (Q4 2025), and $16.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 239.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 119.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 22.60 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 7.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 172.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 19.43 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 21.95 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 22.68 Mn |
| 10 | Ascend Wellness Holdings | - | - | 44.88 Mn | 18.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.28 Mn |
| Mar 31, 2026 | 18.28 Mn |
| Dec 31, 2025 | 20.53 Mn |
| Dec 31, 2025 | 20.53 Mn |
| Sep 30, 2025 | 16.77 Mn |
| Sep 30, 2025 | 16.77 Mn |
| Jun 30, 2025 | 17.83 Mn |
| Jun 30, 2025 | 17.83 Mn |
| Mar 31, 2025 | 18.40 Mn |
| Mar 31, 2025 | 18.40 Mn |
| Dec 31, 2024 | 17.47 Mn |
| Dec 31, 2024 | 17.47 Mn |
| Sep 30, 2024 | 16.63 Mn |
| Sep 30, 2024 | 16.63 Mn |
| Jun 30, 2024 | 15.68 Mn |
| Jun 30, 2024 | 15.68 Mn |
| Mar 31, 2024 | 16.38 Mn |
| Mar 31, 2024 | 16.38 Mn |
| Dec 31, 2023 | 14.79 Mn |
| Dec 31, 2023 | 14.79 Mn |